Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02991677 · ClinicalTrials.gov registry record · NA
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
A NA study of Cancer, Breast and Cancer - Ovarian, sponsored by Baltimore VA Medical Center.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT02991677: Active NA study of Cancer, Breast and Cancer - Ovarian, sponsored by Baltimore VA Medical Center.
NCT02991677 is a NA study of Cancer, Breast and Cancer - Ovarian that is active but no longer recruiting, run by Baltimore VA Medical Center. The registered enrollment target is 60 participants, below the 10,062-participant average among 10 other Cancer, Breast trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02991677, a NA study of Cancer, Breast and Cancer - Ovarian, is active but no longer recruiting, sponsored by Baltimore VA Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-related neuropathic pain (CIPN-NP) will be investigated, with the goal of identifying the mechanisms associated with this therapeutic approach to manage CIPN-NP.
Conditions Studied
Interventions
- OTHER control group
- BEHAVIORAL aerobic exercise intervention
- BEHAVIORAL resistive training
Study Locations (1)
Maryland
- Baltimore VA Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT02991677 still lists
NCT02991677 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 10,062-participant average among 10 other Cancer, Breast trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Cancer, Breast appearing as the primary indexed condition, and to 3 interventions - of which control group is the first listed.
NCT02991677 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02991677 about?
NCT02991677 is a clinical study titled "Exercise Effect on Chemotherapy-Induced Neuropathic Pain". Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-relat...
What is the current status of trial NCT02991677?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2018-03-01. Estimated completion is 2025-12.
What conditions does trial NCT02991677 study?
This clinical trial studies the following conditions: Cancer, Breast, Cancer - Ovarian, Cancer Colorectal, Cancer, Lung.
What interventions are being tested in trial NCT02991677?
The interventions under investigation include: control group (OTHER), aerobic exercise intervention (BEHAVIORAL), resistive training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02991677?
This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02991677 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer, Breast
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02991677's enrollment target sits among peer trials
60 8th of 10 higher than 1 of 10 other Cancer, Breast trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer, Breast trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
RECRUITING · NA
-
Onco-primary Care Networking to Support TEAM-based Care
ACTIVE NOT RECRUITING · NA
-
Translating Research Into Practice: Patient Navigation for Breast Cancer
COMPLETED · NA
-
Decisions About Cancer Screening in Alzheimer's Disease
COMPLETED · NA
-
Comorbidities And Reducing inEquitieS
COMPLETED · NA
-
Tango for Neuropathy Among Breast Cancer Survivors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI